Annual Report 2024

Directors’ Report 董事會報告 112 Sunny Optical Technology (Group) Company Limited • ANNUAL REPORT 2024 於二零二四年六月七日，董事會將有關限制性 股份獎勵計劃項下獎勵的最高限制性股份數目 由佔本公司於採納日期已發行股本的 10% 更新 及修訂為 20,000,000 股股份。於二零二四年六 月七日，根據限制性根據限制性股份獎勵計劃 可供授出的股份合共 20,000,000 股，佔本公司 於二零二四年六月七日已發行股本約 1.83% 。 自二零二四年六月七日至二零二四年十二月 三十一日止，本公司根據限制性股份獎勵計劃 已授出的股份（已扣除此期間內失效的股份）合 共 2,556,885 股。於二零二四年十二月三十一 日（即截至二零二四年十二月三十一日止年度 財務期間的結束），根據限制性股份獎勵計劃可 供授出的股份合共 17,443,115 股，佔本公司於 最後可行日期已發行股本約 1.59% 。 根據限制性股份獎勵計劃可向合資格參與者以 單次或累計授出的限制性股份最高數目不得超 過於採納日期本公司已發行股本的 1% 。 根據限制性股份獎勵計劃，其項下授出的限制 性股份的歸屬期為兩年至五年，且毋須就接納 授出限制性股份而支付任何費用。限制性股份 獎勵計劃項下授出的限制性股份之購買價格為 股份在各授出日期時於香港聯交所的收盤價格。 管理委員會須以本公司資源盡快向受託人支付 於現時、過往或日後授出限制性股份當日的收 市價連同完成購買所有限制性股份所須的所有 相關購買開支。 根據二零二五年三月四日及二零二五年三月五 日本公司公告所披露，本公司委聘中銀國際信 託為受託人，自二零二五年三月三日起生效， 取代將自二零二五年三月三日不再作為受託人 的中銀國際英國保誠，且本公司與中銀國際信 託已於二零二五年三月三日簽立信託契據。 On 7 June 2024, the Board refreshed and amended the maximum number of Restricted Shares to be awarded under the Restricted Share Award Scheme from 10% of the total issued share capital of the Company as at the Adoption Date to 20,000,000 Shares. As at 7 June 2024, the total number of Shares available for grant under the Restricted Share Award Scheme was 20,000,000, representing approximately 1.83% of the Company’s issued shares as at 7 June 2024. From 7 June 2024 to 31 December 2024, a total of 2,556,885 Shares had been granted, net of the Shares lapsed during the period, under the Restricted Share Award Scheme by the Company. As at 31 December 2024 (i.e., the end of the financial period for the year ended 31 December 2024), the total number of Shares available for grant under the Restricted Share Award Scheme is 17,443,115, representing approximately 1.59% of the Company’s issued shares as at the LPD. The maximum number of Restricted Shares which may be granted to an eligible participant under the Restricted Share Award Scheme at any one time or in aggregate may not exceed 1% of the issued share capital of the Company as at the Adoption Date. According to the Restricted Share Award Scheme, the vesting period of the Restricted Shares granted under the Scheme shall be in the period between two to five years and no fees shall be payable on the acceptance of the grant of the Restricted Shares. The purchase price of the grant of the Restricted Shares under the Restricted Share Award Scheme was the closing price of shares on the Hong Kong Stock Exchange on the respective grant date. The Administration Committee shall cause to be paid to the Trustee the sum of the closing price of the Shares as at the date on which the Restricted Share is, was or is to be granted together with all related purchase expenses required for the completion of the purchase of all the Restricted Shares from the Company’s resources as soon as possible. As disclosed in the announcements of the Company dated 4 March 2025 and 5 March 2025, the Company engaged BOCI Trustee as the Trustee with effect from 3 March 2025 purportedly in place of BOCI Prudential which will cease to be the Trustee with effect from 3 March 2025 and a trust deed between the Company and BOCI Trustee was executed on 3 March 2025.